Literature DB >> 3003404

Solubility of calcium oxalate monohydrate and hydroxyapatite in EDTA solutions.

H Verplaetse, R M Verbeeck, A Verbaeys, W Oosterlinck.   

Abstract

The effect of the addition of a buffer to an ethylenediaminetetracetic acid (EDTA) litholytic solution on the solubility of calcium oxalate monohydrate and hydroxyapatite is investigated. The experiments show that the addition of triethanolamine as a buffer to EDTA solutions at pH 8 and 8.5 enhances the solubility of these salts, confirming theoretical predictions. The solubility of calcium oxalate monohydrate at 25C in solutions with varying ratios of buffer to EDTA concentrations and an osmolality of 0.9 was determined. The solutions resulting in the highest solubility were finally tested for their litholytic ability at 37C. At pH 8 solubilities of 22.5 g X l-1 for calcium oxalate monohydrate and 20.2 g X l-1 for hydroxyapatite were obtained. The corresponding solubilities at pH 8.5 were respectively 24.5 g X l-1 and 19.2 g X l-1.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003404     DOI: 10.1016/s0022-5347(17)45760-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Toxicity of litholytic ethylenediaminetetraacetic acid solutions to the urothelium of the rat and dog.

Authors:  W Oosterlinck; R Verbeeck; C Cuvelier; H Verplaetse; A Verbaeys
Journal:  Urol Res       Date:  1991

2.  Rationale for local toxicity of calcium chelators.

Authors:  W Oosterlinck; R Verbeeck; C Cuvelier; D Vergauwe
Journal:  Urol Res       Date:  1992

3.  Urinary extracellular vesicles for RNA extraction: optimization of a protocol devoid of prokaryote contamination.

Authors:  Dorota Tataruch-Weinert; Luca Musante; Oliver Kretz; Harry Holthofer
Journal:  J Extracell Vesicles       Date:  2016-06-24

4.  Therapeutic use of tetrasodium ethylenediaminetetraacetic acid solution for treatment of subcutaneous ureteral bypass device mineralization in cats.

Authors:  Colin Chik; Allyson C Berent; Chick W Weisse; Marcia Ryder
Journal:  J Vet Intern Med       Date:  2019-08-06       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.